Halozyme Therapeutics, Inc. (HALO)
109.62
-1.46
(-1.32%)
USD |
NASDAQ |
Oct 13, 16:00
109.62
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Price : 109.62 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 110.19 | 112.43 | 109.96 | 111.08 | 1.660M |
| Oct 09, 2026 | 109.70 | 112.65 | 109.70 | 110.42 | 1.845M |
| Oct 08, 2026 | 109.41 | 110.64 | 107.41 | 109.84 | 2.490M |
| Oct 07, 2026 | 111.62 | 114.00 | 110.16 | 110.79 | 2.179M |
| Oct 06, 2026 | 108.87 | 111.24 | 107.43 | 109.72 | 1.774M |
| Oct 05, 2026 | 109.62 | 109.87 | 107.68 | 108.31 | 1.856M |
| Oct 02, 2026 | 106.96 | 109.99 | 106.65 | 109.86 | 2.600M |
| Oct 01, 2026 | 109.93 | 110.50 | 106.84 | 106.94 | 2.329M |
| Sep 30, 2026 | 111.54 | 112.45 | 110.35 | 110.40 | 3.521M |
| Sep 29, 2026 | 112.89 | 114.52 | 111.03 | 111.56 | 2.873M |
| Sep 28, 2026 | 113.34 | 113.94 | 112.10 | 112.89 | 2.237M |
| Sep 25, 2026 | 115.36 | 115.62 | 113.43 | 113.90 | 1.958M |
| Sep 24, 2026 | 112.13 | 116.09 | 111.07 | 115.22 | 3.172M |
| Sep 23, 2026 | 116.84 | 116.84 | 112.18 | 112.44 | 2.703M |
| Sep 22, 2026 | 111.50 | 115.18 | 110.95 | 115.13 | 4.152M |
| Sep 21, 2026 | 112.80 | 113.47 | 111.05 | 111.45 | 2.877M |
| Sep 18, 2026 | 109.72 | 112.66 | 109.38 | 112.45 | 10.18M |
| Sep 17, 2026 | 107.08 | 110.88 | 106.82 | 109.68 | 1.984M |
| Sep 16, 2026 | 106.66 | 109.63 | 105.50 | 108.44 | 1.710M |
| Sep 15, 2026 | 108.14 | 108.14 | 106.14 | 106.25 | 1.056M |
| Sep 14, 2026 | 108.00 | 108.61 | 106.65 | 107.94 | 912516.0 |
| Sep 11, 2026 | 107.96 | 108.22 | 106.34 | 107.20 | 861582.0 |
| Sep 10, 2026 | 106.93 | 107.95 | 106.36 | 107.00 | 1.464M |
| Sep 09, 2026 | 107.67 | 108.79 | 106.62 | 107.39 | 1.746M |
| Sep 08, 2026 | 109.00 | 109.96 | 106.07 | 108.31 | 1.626M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AVITA Medical, Inc. | 13.38 |
| Iovance Biotherapeutics, Inc. | 14.50 |
| Merck & Co., Inc. | 142.01 |
| Incyte Corp. | 108.57 |
| Agenus, Inc. | 6.94 |
Price Related Metrics
| PE Ratio | 32.75 |
| PS Ratio | 7.974 |
| Price to Book Value | 87.09 |
| Price to Free Cash Flow | 16.45 |
| Earnings Yield | 3.05% |
| Market Cap | 12.50B |
| Operating PE Ratio | 14.05 |
| Normalized PE Ratio | 20.13 |